Physician profile
Astha Bhatt
NPI 1033468731
$19,530.66
in general payments reported to CMS, 2019-2025
13 companies · $2,108 in 2025
The $2,108 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,380 · 2020: $22.07 · 2021: $6,342 · 2022: $1,425 · 2023: $2,773 · 2024: $4,481 · 2025: $2,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,500 · Travel and Lodging: $1,311 · Consulting Fee: $975 · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,500.00 |
| Travel and Lodging | $1,311.40 |
| Consulting Fee | $975.00 |
| Food and Beverage | $575.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,863.88 | 2019-2025 | Davinci Xi, Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $2,020.03 | 2022-2023 | Signia |
| Biotissue Holdings INC. | $608.37 | 2025 | |
| Tela Bio, INC. | $168.84 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Allergan, INC. | $133.09 | 2019 | |
| Heartflow, INC. | $125.00 | 2022 | |
| Thd America, INC. | $118.39 | 2020-2021 | |
| Endologix LLC | $108.08 | 2021 | |
| Acell, INC. | $105.69 | 2019 | |
| Baxter Healthcare | $100.10 | 2019 | |
| Organogenesis INC. | $22.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Astha Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.